These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2387634)

  • 1. Chlamydial heat shock proteins and trachoma.
    Taylor HR; Maclean IW; Brunham RC; Pal S; Whittum-Hudson J
    Infect Immun; 1990 Sep; 58(9):3061-3. PubMed ID: 2387634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A chlamydial major outer membrane protein extract as a trachoma vaccine candidate.
    Campos M; Pal S; O'Brien TP; Taylor HR; Prendergast RA; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1477-91. PubMed ID: 7601629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies.
    Badamchi-Zadeh A; McKay PF; Holland MJ; Paes W; Brzozowski A; Lacey C; Follmann F; Tregoning JS; Shattock RJ
    PLoS One; 2015; 10(10):e0141209. PubMed ID: 26501198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydia-specific lymphocytes in conjunctiva during ocular infection: limiting dilution analysis.
    Pal S; Pu Z; Huneke RB; Taylor HR; Whittum-Hudson JA
    Reg Immunol; 1990-1991; 3(4):171-6. PubMed ID: 1716948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of trachoma: the stimulus for inflammation.
    Taylor HR; Johnson SL; Schachter J; Caldwell HD; Prendergast RA
    J Immunol; 1987 May; 138(9):3023-7. PubMed ID: 3571982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inapparent ocular infection by Chlamydia trachomatis in experimental and human trachoma.
    Hudson AP; McEntee CM; Reacher M; Whittum-Hudson JA; Taylor HR
    Curr Eye Res; 1992 Mar; 11(3):279-83. PubMed ID: 1375138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral immunization with chlamydial major outer membrane protein (MOMP).
    Taylor HR; Whittum-Hudson J; Schachter J; Caldwell HD; Prendergast RA
    Invest Ophthalmol Vis Sci; 1988 Dec; 29(12):1847-53. PubMed ID: 3192374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of B-cell responses to Chlamydia trachomatis antigens in humans with trachoma.
    Ghaem-Maghami S; Bailey RL; Mabey DC; Hay PE; Mahdi OS; Joof HM; Whittle HC; Ward ME; Lewis DJ
    Infect Immun; 1997 Dec; 65(12):4958-64. PubMed ID: 9393782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of antigen-specific B cells during experimental ocular Chlamydia trachomatis infection.
    Pal S; Taylor HR; Huneke RB; Prendergast RA; Whittum-Hudson JA
    Infect Immun; 1992 Dec; 60(12):5294-7. PubMed ID: 1452363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attempted oral immunization with chlamydial lipopolysaccharide subunit vaccine.
    Taylor HR; Prendergast RA
    Invest Ophthalmol Vis Sci; 1987 Oct; 28(10):1722-6. PubMed ID: 3308760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection.
    Whittum-Hudson JA; An LL; Saltzman WM; Prendergast RA; MacDonald AB
    Nat Med; 1996 Oct; 2(10):1116-21. PubMed ID: 8837610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular delayed hypersensitivity: a pathogenetic mechanism of chlamydial-conjunctivitis in guinea pigs.
    Watkins NG; Hadlow WJ; Moos AB; Caldwell HD
    Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7480-4. PubMed ID: 3463978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydial hsp60 and the immunopathogenesis of chlamydial disease.
    Morrison RP
    Semin Immunol; 1991 Jan; 3(1):25-33. PubMed ID: 1680011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A poliovirus hybrid expressing a neutralization epitope from the major outer membrane protein of Chlamydia trachomatis is highly immunogenic.
    Murdin AD; Su H; Manning DS; Klein MH; Parnell MJ; Caldwell HD
    Infect Immun; 1993 Oct; 61(10):4406-14. PubMed ID: 7691749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjunctival scarring in trachoma is associated with depressed cell-mediated immune responses to chlamydial antigens.
    Holland MJ; Bailey RL; Hayes LJ; Whittle HC; Mabey DC
    J Infect Dis; 1993 Dec; 168(6):1528-31. PubMed ID: 8245540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteome array of antibody responses to Chlamydia trachomatis infection in nonhuman primates.
    Lu C; Sun Z; Chen H; Chen L; Zhu C; Chen C; Li C; Peng B; Zhong G
    Life Sci; 2020 May; 248():117444. PubMed ID: 32084433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An animal model for cicatrizing trachoma.
    Taylor HR; Prendergast RA; Dawson CR; Schachter J; Silverstein AM
    Invest Ophthalmol Vis Sci; 1981 Sep; 21(3):422-33. PubMed ID: 7275529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential human serologic response to two 60,000 molecular weight Chlamydia trachomatis antigens.
    Wagar EA; Schachter J; Bavoil P; Stephens RS
    J Infect Dis; 1990 Oct; 162(4):922-7. PubMed ID: 2205652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydial disease pathogenesis. Ocular hypersensitivity elicited by a genus-specific 57-kD protein.
    Morrison RP; Lyng K; Caldwell HD
    J Exp Med; 1989 Mar; 169(3):663-75. PubMed ID: 2926323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Chlamydia trachomatis bacterial ghost vaccine to fight human blindness.
    Eko FO; Talin BA; Lubitz W
    Hum Vaccin; 2008; 4(3):176-83. PubMed ID: 18382139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.